Introduction & Objective: Prior research demonstrated an association between historical redlining practices and diabetes-related mortality. The National DPP is an evidence-based, cost-effective, structured lifestyle change intervention to prevent type 2 diabetes (T2D). Whether historical redlining practices drive the present-day availability of DPP programs across the US is unknown.

Methods: In person and hybrid DPPs across the US and their addresses were identified from the CDC. Walking distance accessibility was defined as a 0.8 km radius. Redlining was assessed using the 1930s federal Home Owners’ Loan Corporation (HOLC) maps by intersect spatial join onto 2020 census tracts. HOLC areas are classified into 4 grades: A (best), B (still desirable), C (declining), and D (hazardous). We examined the association between grade D vs. A-C tracts and the number of DPPs using a negative binomial mixed-effects model with random intercepts by geographic level and controlling for tract-level population, proportion uninsured people, and <150% of federal poverty line (FPL).

Results: Of 1730 DPPs, 347 were within walking access of a HOLC-graded tract centroid in 38 states. Nationally, after controlling for tract-level characteristics, grade D tracts and tracts with greater proportion <150% of FPL were associated with greater number of DPPs, while tracts with greater proportion of uninsured were associated with fewer DPPs within walking distance. In state-specific analyses for 7 of 33 examined states, there was statistically significant greater than expected DPP availability in grade D tracts. There was no difference in 20 states, while remaining 11 states could not be examined due to lack of HOLC data, model diagnostics, data sparsity, or convergence failure.

Conclusion: While availability of walking distance DPPs is higher in historically redlined areas in 7 states, there was no such enrichment in 20 states. Future research needs to examine DPP utilization by residents in these communities.

Disclosure

D.J. Roy: None. T. Chantarat: None. D.H. Jiang: None. S. Golden: None. E. Davis: None. M.L. Ding: None. S.J. Huang: None. R.G. McCoy: Research Support; American Diabetes Association. Other Relationship; American Diabetes Association. Consultant; Wolters Kluwer Health. Research Support; National Institutes of Health, Patient-Centered Outcomes Research Institute. Consultant; Yale New Haven Health System.

Funding

National Institute of Diabetes and Digestive and Kidney Diseases (K23DK114497)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.